Paraoxonase 1: A better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 7, Issue 2, 2013, Pages 108-111

  Patra, Surajeet Kumar ^a   Singh, Kamna ^a   Singh, Ritu ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Atherogenic coefficient (AC); Atherogenic index of plasma (AIP); Castelli's risk index I (CRII); Castelli's risk index II (CRI II); Paraoxonase 1(PON 1)

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN;

ADULT; ANALYTICAL RESEARCH; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SAMPLE SIZE;

ADULT; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84877739237     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.02.007     Document Type: Article

References (8)

1. P.J. Randle Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after thirty five years Diabetes/Metabolism Reviews 14 1998 263 283
2. B. Mackness, M.I. Mackness, S. Arrol, W. Turkie, K. Julier, and B. Abuashia Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus Atherosclerosis 139 1998 341 349
3. J. Marsillach, B. Mackness, M. Mackness, F. Riu, R. Beltran, and J. Joven Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues Free Radical Biology and Medicine 45 2008 146 157
4. L.P. Précourta, D. Amreb, M.C. Denisa, J.C. Lavoieb, E. Delvinc, and E. Seidmand The three-gene paraoxonase family: physiologic roles, actions and regulation Atherosclerosis 214 2011 20 36
5. R. Suvarna, S.S. Rao, C. Joshi, V. Kedage, M.S. Muttigi, and J.K. Shetty Paraoxonase activity in type 2 diabetes mellitus patients with and without complications Journal of Clinical and Diagnostic Research 5 1 2011 63 65
6. P.W. Connelly, B. Zinman, G.F. Maguire, M. Mamakeesick, S.B. Harris, and R.A. Hegele Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes Journal of Lipid Research 50 2009 1216 1222
7. M. Aviram, and M. Rosenblat Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development Free Radical Biology and Medicine 37 2004 1304 1316
8. D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, and J. Loscalzo Harrison's principles of internal medicine 18th ed. 2012 McGraw-Hill USA (Chapter 344, Diabetes Mellitus)